| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/29/2013 | US8361778 Composition comprising enzymatically digested yeast cells and method of preparing same |
| 01/29/2013 | US8361777 Genes for biosynthesis of tetracycline compounds and uses thereof |
| 01/29/2013 | US8361773 Polynucleotides encoding polypeptides and host cells therefor |
| 01/29/2013 | US8361770 Genetically programmed expression of selectively sulfated proteins in Eubacteria |
| 01/29/2013 | US8361767 BGL7 beta-glucosidase and nucleic acids encoding the same |
| 01/29/2013 | US8361765 Enzymic method for the enantioselective reduction of keto compounds |
| 01/29/2013 | US8361761 Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor |
| 01/29/2013 | US8361760 Microbial production of 3-hydroxyacids from glucose and glycolate |
| 01/29/2013 | US8361758 Microorganism of Corynebacterium genus having resistance to kanamycin and enhanced L-lysine productivity and method of producing L-lysine using the same |
| 01/29/2013 | US8361755 Compositions and methods for grain processing without pH adjustment |
| 01/29/2013 | US8361747 Antibodies against human angiopoietin 2 |
| 01/29/2013 | US8361741 Serum-free growth medium for Acholeplasma laidlawii and methods for retention testing sterilizing grade filters |
| 01/29/2013 | US8361729 Detection of cells expressing T1R2 taste receptor |
| 01/29/2013 | US8361481 Lactic acid bacterium having anti-allergic activity and pharmaceutical composition |
| 01/29/2013 | US8361480 Attenuated ehrlichiosis vaccine |
| 01/29/2013 | US8361478 Recombinant viral-based malaria vaccines |
| 01/29/2013 | US8361466 Tweak receptor |
| 01/29/2013 | CA2677781C Nitrilases |
| 01/29/2013 | CA2557295C Improved bacterial host cell for the direct expression of peptides |
| 01/29/2013 | CA2482995C Low-cost production of peptides |
| 01/29/2013 | CA2477975C Novel vip3 toxins and methods of use |
| 01/29/2013 | CA2462113C Multi-chain eukaryotic display vectors and uses thereof |
| 01/29/2013 | CA2431891C Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 01/29/2013 | CA2322160C Vaccines, immunotherapeutics and methods for using the same |
| 01/24/2013 | WO2013012975A1 Methods for increasing product yields |
| 01/24/2013 | WO2013012674A1 Methods of transcription activator like effector assembly |
| 01/24/2013 | WO2013012329A1 Method for obtaining an open phototrophic culture with improved storage compound production capacity |
| 01/24/2013 | WO2013012293A2 Method for preparing diol compound at high yield using glycerol fermentation microorganism variant |
| 01/24/2013 | WO2013012121A1 Apparatus for reducing carbon dioxide using microalgae, and method for reducing carbon dioxide using same |
| 01/24/2013 | WO2013011320A2 Probiotic formulation |
| 01/24/2013 | WO2013011292A2 A Micro-organism |
| 01/24/2013 | WO2013011142A1 New actinomycete strain composition and its use |
| 01/24/2013 | WO2013010937A1 Process of lysing yeast cell walls |
| 01/24/2013 | WO2013010260A1 Isolated brachyspira and methods and compositions for expanding and isolating brachyspira |
| 01/24/2013 | WO2012166408A3 Genetically modified e. coli strains for producing erythromycin analogs |
| 01/24/2013 | WO2012161522A3 Microorganism found in the corynebacterium genus having enhanced l-ornithine production and method for preparing l-ornithine using same |
| 01/24/2013 | WO2012157989A3 Avirulent modified salmonella gallinarum strains and pharmaceutical composition using the same |
| 01/24/2013 | WO2012106560A9 Tailored oils produced from recombinant oleaginous microorganisms |
| 01/24/2013 | US20130025006 MODIFIED Cry1Ca INSECTICIAL Cry PROTEINS |
| 01/24/2013 | US20130025005 Polypeptides Having Lipase Activity And Polynucleotides Encoding Same |
| 01/24/2013 | US20130024956 Antibodies to cd40 |
| 01/24/2013 | US20130023654 Antibodies to matrix metalloproteinase 9 |
| 01/24/2013 | US20130023647 Modified human thymic stromal lymphopoietin |
| 01/24/2013 | US20130023565 Influenza a 2009 pandemic h1n1 polypeptide fragments comprising endonuclease activity and their use |
| 01/24/2013 | US20130023478 Aquaretic and natriuretic polypeptides lacking vasodilatory activity |
| 01/24/2013 | US20130023477 Growth hormone fusion proteins |
| 01/24/2013 | US20130023474 Compositions, uses and methods for treatment of metabolic disorders and diseases |
| 01/24/2013 | US20130023461 Oligopeptide compounds and uses thereof |
| 01/24/2013 | US20130023421 Protein display |
| 01/24/2013 | US20130023053 Methods and compositions for targeted mutagenesis in bacteria |
| 01/24/2013 | US20130023041 Method and Apparatus for Holding Cells |
| 01/24/2013 | US20130023036 Nucleic acid construct, recombinant vector, and recombinant e. coli producing chicken anemia virus vp1 protein |
| 01/24/2013 | US20130023035 Regulation of toxin and antitoxin genes for biological containment |
| 01/24/2013 | US20130023033 Pharmacologically induced transgene ablation system |
| 01/24/2013 | US20130023029 Novel asparaginases and uses thereof |
| 01/24/2013 | US20130023028 Variants Of A Polypeptide With Lipolytic Activity and Improved Stability |
| 01/24/2013 | US20130023025 Method for separating cells, cell culture substrate, and device for separating cells |
| 01/24/2013 | US20130023022 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities |
| 01/24/2013 | US20130023021 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities |
| 01/24/2013 | US20130023019 Processing Biomass |
| 01/24/2013 | US20130023017 Method for producing pyripyropene |
| 01/24/2013 | US20130023016 L-ornithine or l-arginine producing strain and method for producing l-ornithine or l-arginine |
| 01/24/2013 | US20130023014 Novel cellulase gene |
| 01/24/2013 | US20130023012 Recombinase-Based Methods for Producing Expression Vectors and Compositions for Use in Practicing the Same |
| 01/24/2013 | US20130022999 Protein fragment complementation assays for the detection of biological or drug interactions |
| 01/24/2013 | US20130022988 Yeast cells expressing amyloid beta and uses therefor |
| 01/24/2013 | US20130022642 Dual Antagonist for TNF-A and IL-21 for Preventing and Treating Autoimmune Diseases |
| 01/24/2013 | US20130022639 Expression of meningococcal fhbp polypeptides |
| 01/24/2013 | US20130022634 New composition and methods for treatment of autoimmune and allergic diseases |
| 01/24/2013 | US20130022633 MENINGOCOCCAL fHBP POLYPEPTIDES |
| 01/24/2013 | US20130022616 Interleukin-31 Monoclonal Antibody |
| 01/24/2013 | US20130022607 Mucosal vascular addressins and uses thereof |
| 01/24/2013 | US20130022606 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 01/24/2013 | US20130022605 Antagonists against tnfr1 and methods of use therefor |
| 01/24/2013 | US20130022597 Antibodies Directed To GPNMB And Uses Thereof |
| 01/24/2013 | US20130022586 Production and use of bacterial histamine |
| 01/24/2013 | US20130022578 Methods and system for interfering with viability of bacteria and related compounds and compositions |
| 01/24/2013 | US20130022575 Systems and methods of replacing intestinal flora |
| 01/24/2013 | US20130022553 Novel polyamino polyketide antibiotics and uses thereof |
| 01/24/2013 | US20130022547 Attenuated mycoplasma gallisepticum strains |
| 01/24/2013 | US20130022539 Ovr115 antibody compositions and methods of use |
| 01/24/2013 | CA2842374A1 Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof |
| 01/24/2013 | CA2842068A1 Isolated brachyspira and methods and compositions for expanding and isolating brachyspira |
| 01/24/2013 | CA2841710A1 Methods of transcription activator like effector assembly |
| 01/24/2013 | CA2841164A1 Attenuated plasmodium with deactivated hmgb2 gene, as vaccine |
| 01/23/2013 | EP2548973A1 New actinomycete strain composition and its use |
| 01/23/2013 | EP2548968A1 Method of producing astaxanthin by fermentation |
| 01/23/2013 | EP2548957A1 Method for producing kluyveromyces marxianus transformant |
| 01/23/2013 | EP2548949A2 Microorganism with improved production of 5'-xanthosine monophosphate and 5'-guanine monophosphate, and production method of 5'-xanthosine monophosphate and 5'-guanine monophosphate using same |
| 01/23/2013 | EP2548948A1 Novel lactobacillus classified as lactobacillus plantarum, and use thereof |
| 01/23/2013 | EP2548947A1 Transformant which produces glycine repeat protein |
| 01/23/2013 | EP2548946A1 Process for producing granular and microbiologically active natural yeast |
| 01/23/2013 | EP2548945A2 Lactic acid bacterium with increased acid tolerance |
| 01/23/2013 | EP2548944A1 Process of lysing yeast cell walls |
| 01/23/2013 | EP2548455A1 Equol-producing lactic acid bacteria-containing composition |
| 01/23/2013 | EP2547777A2 Processes using antibiotic alternatives in bioethanol production |
| 01/23/2013 | EP2547767A2 Use of achromopeptidase for lysis at room temperature |
| 01/23/2013 | EP2547759A2 A novel ethanologenic clostridium species, clostridium coskatii |
| 01/23/2013 | CN102892892A Process for production of isopropanol, and genetically modified yeast capable of producing isopropanol |
| 01/23/2013 | CN102892887A Method for improving flavor production in a fermented food product |